Thromboembolic events, major bleeding and mortality in essential thrombocythaemia and polycythaemia vera—A matched nationwide population‐based study
British Journal of Haematology · 2024
DOI: 10.1111/bjh.19337 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, 2024. Verfasst von Anneli Enblom-Larsson und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden. Hauptthemen laut MEDLINE: Thrombocythemia, Essential, Hemorrhage, Polycythemia Vera, Thromboembolism. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The Stroke Foundation of Northern Sweden, The Swedish Stroke Fund, FoU Region Norrbotten.
Abstract (Originalsprache)
Thromboembolic events and bleeding are known complications in essential thrombocythaemia (ET) and polycythaemia vera (PV). Using multiple Swedish health care registers, we assessed the rate of arterial and venous events, major bleeding, all‐cause stroke and all‐cause mortality in ET and PV compared to matched controls. For each patient with ET ( n = 3141) and PV ( n = 2604), five matched controls were randomly selected. In total, 327 and 405 arterial or venous events were seen in the group of ET and PV patients respectively. Compared to corresponding controls, the rate of venous thromboembolism, major bleeding and all‐cause mortality per 100 treatment years was significantly increased among both ET (0.63, 0.79 and 3.70) and PV patients (0.94, 1.20 and 4.80). The PV patients also displayed a significantly higher rate of arterial events and all‐cause stroke compared to controls. When dividing the cohort into age groups, we found a significantly higher rate of arterial and venous events in all age groups of PV patients, and the rate of all‐cause mortality was significantly higher in both ET and PV patients in all ages above the age of 50. This study confirms that PV and ET are diseases truly marked by thromboembolic complications and bleeding.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
- Uppsala Clinical Research Centre Uppsala University, Uppsala, Sweden.
- NU Hospital Group, Uddevalla, Sweden.
- Department of Epidemiology and Global Health, Umeå University, Umeå, Sweden.
- Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden.
ORCID-Profile: Anneli Enblom-Larsson
Förderung
- The Stroke Foundation of Northern Sweden
- The Swedish Stroke Fund
- FoU Region Norrbotten
- The Emil Andersson Research Fund
- Visare Norr
Zitieren
APA
Enblom-Larsson, A., Renlund, H., Andréasson, B., Holmberg, H., Liljeholm, M., & Själander, A. (2024). Thromboembolic events, major bleeding and mortality in essential thrombocythaemia and polycythaemia vera—A matched nationwide population‐based study. British Journal of Haematology. https://doi.org/10.1111/bjh.19337
Vancouver
Enblom-Larsson A, Renlund H, Andréasson B, Holmberg H, Liljeholm M, Själander A. Thromboembolic events, major bleeding and mortality in essential thrombocythaemia and polycythaemia vera—A matched nationwide population‐based study. British Journal of Haematology. 2024. doi:10.1111/bjh.19337
BibTeX
@article{EnblomLarsson2024,
author = {Enblom-Larsson, Anneli and Renlund, Henrik and Andréasson, Björn and Holmberg, Henrik and Liljeholm, Maria and Själander, Anders},
title = {Thromboembolic events, major bleeding and mortality in essential thrombocythaemia and polycythaemia vera—A matched nationwide population‐based study},
journal = {British Journal of Haematology},
year = {2024},
doi = {10.1111/bjh.19337}
}
EUVIMED